KURIYEL RALF
SEC CIK 1733143 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Senior VP, R, D | 20.1K | — | $4.92M | 35 | 2021-08-30 | 2026-03-05 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
| 11 | KURIYEL RALF | Senior VP, R, D | — | — |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-23 | 2026-03-05 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +5,284 | 20.1K | +36% | $0 |
| 2026-03-05 | 2026-03-04 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +125 | 14.8K | +0.9% | $0 | |
| 2026-03-05 | 2026-03-04 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $125.84 | -42 | 14.8K | -0.3% | -$5,285 | |
| M | 2026-03-03 | 2026-02-27+ | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $126.19 | -1,367 | 14.7K | -9% | -$172.5K |
| D | 2025-03-04 | 2025-03-03 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +4,826 | 16.4K | +42% | $0 |
| D | 2025-03-04 | 2025-03-03 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $155.38 | -386 | 16.1K | -2% | -$60.0K |
| 2025-02-28 | 2025-02-27 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $156.54 | -391 | 11.6K | -3% | -$61.2K | |
| 2025-02-25 | 2025-02-24 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $164.74 | -275 | 12.0K | -2% | -$45.3K | |
| DM | 2024-08-05 | 2024-08-02 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $159.35 | -7,148 | 12.3K | -37% | -$1.14M |
| D | 2024-08-05 | 2024-08-02 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | M - OptEx | $86.10 | +175 | 12.5K | +1% | +$15.1K |
| 2024-08-01 | 2024-08-01 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | S - Sale | $165.67 | -4,465 | 19.3K | -19% | -$739.7K | |
| 2024-05-15 | 2024-05-14 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $163.34 | -534 | 23.7K | -2% | -$87.2K | |
| D | 2024-03-12 | 2024-03-11 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $193.73 | -3,517 | 24.3K | -13% | -$681.3K |
| D | 2024-03-12 | 2024-03-11 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | M - OptEx | $86.10 | +1,271 | 27.8K | +5% | +$109.4K |
| 2024-03-07 | 2024-03-07 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $195.72 | -386 | 26.5K | -1% | -$75.5K | |
| 2024-03-06 | 2024-03-04 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $193.99 | -135 | 26.9K | -0.5% | -$26.2K | |
| 2024-03-04 | 2024-03-01 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $191.79 | -453 | 27.0K | -2% | -$86.9K | |
| 2024-03-04 | 2024-02-29 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +404 | 27.5K | +1% | $0 | |
| D | 2024-02-29 | 2024-02-27 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +3,520 | 27.1K | +15% | $0 |
| 2023-05-16 | 2023-05-16 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $154.03 | -710 | 23.6K | -3% | -$109.4K | |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +7,059 | 25.5K | +38% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $188.00 | -1,247 | 24.3K | -5% | -$234.4K |
| 2023-03-01 | 2023-02-28 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $173.28 | -358 | 18.5K | -2% | -$62.0K | |
| 2023-02-28 | 2023-02-28 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $173.44 | -458 | 18.8K | -2% | -$79.4K | |
| DM | 2022-08-12 | 2022-08-11 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | M - OptEx | $50.58 | +4,000 | 22.1K | +22% | +$202.3K |
| DM | 2022-08-12 | 2022-08-11 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | S - Sale+OE | $254.32 | -4,840 | 23.3K | -17% | -$1.23M |
| 2022-05-17 | 2022-05-13 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $150.40 | -712 | 20.1K | -3% | -$107.1K | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $196.70 | -2,534 | 18.6K | -12% | -$498.4K |
| 2022-03-02 | 2022-02-28 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +4,234 | 22.4K | +23% | $0 | |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +2,126 | 19.3K | +12% | $0 |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $189.21 | -188 | 19.1K | -1.0% | -$35.6K |
| 2022-02-22 | 2022-02-17 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | A - Grant | $0.00 | +450 | 17.4K | +3% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $182.42 | -175 | 17.2K | -1% | -$31.9K | |
| 2021-12-15 | 2021-12-14 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | F - Tax | $252.53 | -445 | 16.9K | -3% | -$112.4K | |
| 2021-09-02 | 2021-08-30 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R, D | S - Sale | $282.13 | -4,001 | 17.4K | -19% | -$1.13M |
Purchase Sale Sale after option exercise All abbreviations